Vaccine Preventable Illness After Blinatumomab Therapy: A Case Report
- Katie Voelz,
- Anthony Salvatore,
- Sudarshawn Damodharan,
- Cathy Lee-Miller
Katie Voelz
University of Wisconsin-Madison Department of Pediatrics
Corresponding Author:kvoelz@uwhealth.org
Author ProfileAnthony Salvatore
University of Wisconsin-Madison Department of Pediatrics
Author ProfileSudarshawn Damodharan
University of Wisconsin-Madison Department of Pediatrics
Author ProfileCathy Lee-Miller
University of Wisconsin-Madison Department of Pediatrics
Author Profile18 Oct 2022Submitted to Pediatric Blood & Cancer 18 Oct 2022Submission Checks Completed
18 Oct 2022Assigned to Editor
18 Oct 2022Review(s) Completed, Editorial Evaluation Pending
18 Oct 2022Reviewer(s) Assigned
25 Oct 2022Editorial Decision: Revise Major
05 Dec 2022Submission Checks Completed
05 Dec 2022Assigned to Editor
05 Dec 20221st Revision Received
05 Dec 2022Review(s) Completed, Editorial Evaluation Pending
05 Dec 2022Reviewer(s) Assigned
31 Dec 2022Editorial Decision: Revise Minor
13 Jan 2023Submission Checks Completed
13 Jan 2023Assigned to Editor
13 Jan 20232nd Revision Received
13 Jan 2023Review(s) Completed, Editorial Evaluation Pending
13 Jan 2023Editorial Decision: Accept